Literature DB >> 16369717

Results of preoperative lymphoscintigraphy for breast cancer are predictive of identification of axillary sentinel lymph nodes.

Frédéric Marchal1, Philippe Rauch, Olivier Morel, Jean Claude Mayer, Pierre Olivier, Agnès Leroux, Jean Luc Verhaeghe, François Guillemin.   

Abstract

The aim of this study was to identify the variables associated with successful peroperative sentinel lymph node (SLN) localization. We studied 201 patients with T1, T2, N0 invasive breast cancer who underwent a SLN procedure from 1999 to 2003. Of these 201 patients, 55 underwent peritumoral and 146 underwent periareolar radioisotope injection before the blue dye injection. All patients were operated on by breast conservative surgery and axillary dissection after SLN biopsy. Age, weight, menopausal status, previous biopsy, localization of the tumor, results of lymphoscintigraphy, site of radiotracer injection, tumor size, tumor grade, experience of surgeons, and the number of invaded axillary nodes were analyzed to determine whether they had any significant correlation with successful identification of SLN. Variables found to have a statistically significant influence on the SLN identification rate and on preoperative lymphoscintigraphy identification were introduced into a univariate and multivariate logistic regression model. In multivariate analysis, successful lymphoscintigraphy (P < 0.0001) and the absence of metastatic axillary nodes (P < 0.005) were associated with successful identification of SLNs. The peritumoral injection of radiotracer (P < 0.001), patient age > 60 years (P < 0.003), and localization of the tumor in the upper outer quadrant (P < 0.004) were associated with failure of lymphoscintigraphic visualization of SLN. The technique of SLN detection thus appears to be better for patients with low risk of invaded axillary lymph nodes.

Entities:  

Mesh:

Year:  2006        PMID: 16369717     DOI: 10.1007/s00268-005-0145-3

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  46 in total

1.  Factors affecting sentinel node localization during preoperative breast lymphoscintigraphy.

Authors:  P I Haigh; N M Hansen; A E Giuliano; G K Edwards; W Ye; E C Glass
Journal:  J Nucl Med       Date:  2000-10       Impact factor: 10.057

2.  Lymphoscintigraphic anatomy of sentinel lymphatic channels after subareolar injection of Technetium 99m sulfur colloid.

Authors:  K A Kern
Journal:  J Am Coll Surg       Date:  2001-12       Impact factor: 6.113

Review 3.  How many cases are enough for accreditation in sentinel lymph node biopsy in breast cancer?

Authors:  Elias E Sanidas; Eelco de Bree; Dimitris D Tsiftsis
Journal:  Am J Surg       Date:  2003-03       Impact factor: 2.565

4.  Subareolar injection of 99mTc facilitates sentinel lymph node identification.

Authors:  Todd M Tuttle; Marybeth Colbert; Robert Christensen; Kevin J Ose; Thomas Jones; Robert Wetherille; Joel Friedman; Karen Swenson; Kelly M McMasters
Journal:  Ann Surg Oncol       Date:  2002 Jan-Feb       Impact factor: 5.344

5.  Sentinel lymphadenectomy in breast cancer.

Authors:  A E Giuliano; R C Jones; M Brennan; R Statman
Journal:  J Clin Oncol       Date:  1997-06       Impact factor: 44.544

6.  The hidden sentinel node in breast cancer.

Authors:  P J Tanis; J W van Sandick; O E Nieweg; R A Valdés Olmos; E J T Rutgers; C A Hoefnagel; B B R Kroon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-03       Impact factor: 9.236

7.  Impact of axillary nodal metastases on lymphatic mapping and sentinel lymph node identification rate in patients with early stage breast cancer.

Authors:  Ettore Pelosi; Ada Ala; Marilena Bellò; Anastasios Douroukas; Giuseppe Migliaretti; Ester Berardengo; Teresio Varetto; Riccardo Bussone; Gianni Bisi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-04-19       Impact factor: 9.236

Review 8.  Lymphatic mapping and sentinel lymph node biopsy in breast cancer.

Authors:  O E Nieweg; L Jansen; R A Valdés Olmos; E J Rutgers; J L Peterse; K A Hoefnagel; B B Kroon
Journal:  Eur J Nucl Med       Date:  1999-04

9.  Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy.

Authors:  Anees Chagpar; Robert C Martin; Celia Chao; Sandra L Wong; Michael J Edwards; Todd Tuttle; Kelly M McMasters
Journal:  Arch Surg       Date:  2004-06

10.  Mammary lymphoscintigraphy in breast cancer.

Authors:  R F Uren; R B Howman-Giles; J F Thompson; D Malouf; G Ramsey-Stewart; F W Niesche; S B Renwick
Journal:  J Nucl Med       Date:  1995-10       Impact factor: 10.057

View more
  8 in total

1.  Removal of all radioactive sentinel nodes in breast cancer improves the detection of positive sentinel nodes.

Authors:  I Rubio; F Pedreira; I Roca; A Cabaleiro; C Mendoza; O Córdoba; T Cortadellas; D Sabadell; J Xercavins
Journal:  Clin Transl Oncol       Date:  2008-06       Impact factor: 3.405

2.  Fluorescence imaging and whole-body biodistribution of near-infrared-emitting quantum dots after subcutaneous injection for regional lymph node mapping in mice.

Authors:  Emilie Pic; Thomas Pons; Lina Bezdetnaya; Agnès Leroux; François Guillemin; Benoît Dubertret; Frédéric Marchal
Journal:  Mol Imaging Biol       Date:  2009-11-21       Impact factor: 3.488

Review 3.  Advantage of sentinel lymph node biopsy before neoadjuvant chemotherapy in breast cancer treatment.

Authors:  Hirotaka Iwase; Yutaka Yamamoto; Teru Kawasoe; Mutsuko Ibusuki
Journal:  Surg Today       Date:  2009-04-30       Impact factor: 2.549

4.  A dual-modal magnetic nanoparticle probe for preoperative and intraoperative mapping of sentinel lymph nodes by magnetic resonance and near infrared fluorescence imaging.

Authors:  Zhengyang Zhou; Hongwei Chen; Malgorzata Lipowska; Liya Wang; Qiqi Yu; Xiaofeng Yang; Diana Tiwari; Lily Yang; Hui Mao
Journal:  J Biomater Appl       Date:  2013-07       Impact factor: 2.646

5.  The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer.

Authors:  Francesco Giammarile; Naomi Alazraki; John N Aarsvold; Riccardo A Audisio; Edwin Glass; Sandra F Grant; Jolanta Kunikowska; Marjut Leidenius; Valeria M Moncayo; Roger F Uren; Wim J G Oyen; Renato A Valdés Olmos; Sergi Vidal Sicart
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-10-02       Impact factor: 9.236

6.  Quantum dots in axillary lymph node mapping: biodistribution study in healthy mice.

Authors:  Anne Robe; Emilie Pic; Henri-Pierre Lassalle; Lina Bezdetnaya; François Guillemin; Frédéric Marchal
Journal:  BMC Cancer       Date:  2008-04-22       Impact factor: 4.430

Review 7.  The sentinel node in breast cancer.

Authors:  Conor D Collins
Journal:  Cancer Imaging       Date:  2008-10-04       Impact factor: 3.909

8.  Biological Subtypes of Breast Cancer and Sentinel Lymph Node Biopsy.

Authors:  Muhammet Kadri Çolakoğlu; Erhan Güven; Gökhan Giray Akgül; Lütfi Doğan; Mehmet Ali Gülçelik
Journal:  Eur J Breast Health       Date:  2018-04-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.